A Randomized, Multicenter, Parallel Design Phase III Clinical Study to Evaluate the Efficacy and Safety of the Combination of Lercanidipine/Valsartan in Hypertensive Patients Who Are Not Adequately Controlled on Lercanidipine 10mg Monotherapy.

Trial Profile

A Randomized, Multicenter, Parallel Design Phase III Clinical Study to Evaluate the Efficacy and Safety of the Combination of Lercanidipine/Valsartan in Hypertensive Patients Who Are Not Adequately Controlled on Lercanidipine 10mg Monotherapy.

Completed
Phase of Trial: Phase III

Latest Information Update: 29 Jul 2015

At a glance

  • Drugs Lercanidipine/valsartan (Primary) ; Lercanidipine
  • Indications Essential hypertension
  • Focus Registrational; Therapeutic Use
  • Most Recent Events

    • 29 Jul 2015 Planned number of patients changed from 449 to 497.
    • 08 Jul 2015 Results published in the Clinical Therapeutics.
    • 01 Sep 2013 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top